Arizona Society of Pathologists
  • Home
  • MEETINGS
    • Fall 2023 Meeting
    • Fall 2022 Meeting
    • Fall 2021 Meeting
    • Fall 2020 Virtual Meeting
    • Spring 2019
    • Fall 2018 >
      • Fall 2018 Presentations
    • Spring 2018
    • Fall 2016
    • Spring 2016
    • Fall 2014
    • Spring 2014
    • Fall 2013
    • Spring 2013
  • Membership
    • Online Payments
  • Officers
  • Contact
  • Privacy Policy
  • 2023 COMMERCIAL SUPPORT
  • 2022 COMMERCIAL SUPPORT
  • Job Openings

COMMERCIAL SUPPORT

The Arizona Society of Pathologists thanks the commercial supporters listed below for their valued support of our 2023 Annual Meeting, to be held on Saturday, November 18 as a hybrid meeting.
Picture
​

PLATINUM LEVEL COMMERCIAL SUPPORTERS

Adaptative Biotechnologies

Picture

                                                      AstraZeneca

Picture
​AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit us at www.astrazeneca-us.com and www.azprecisionmed.com.

Blueprint Medicines

Picture

Castle Biosciences

Picture

Daiichi-Sankyo

Picture

Interpace Diagnostics

Picture
GOLD LEVEL COMMERCIAL SUPPORTERS

StatLab Medical Products

Picture
 SILVER LEVEL COMMERCIAL SUPPORTERS

APS Medical Billing

Picture

Biocare Medical

Picture

Merck & Co., Inc.

Picture

 ​                                      Novartis Precision Medicine 

Picture
Novartis Precision Medicine has one mission: to improve patient care by increasing the number of patients who are tested for each and every relevant, actionable biomarker. The path from testing, to diagnosis, to treatment is challenging to navigate. We understand the importance of clinical decisions and the complexity of making them. We can partner with you to provide our expertise in order to advance biomarker testing for patients.
 
That’s why our motto is “If you have testing questions, we have testing answers"
 
John Holton
+1 303 868 3956
john.holton_ext@novartis.com
​

Recordati Rare Diseases

Picture